Application of Two Different Synthetic Sequential Media for the Human IVF-Embryo Transfer (IVF-ET) Program
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Quality-controlled commercial media have been used in many in-vitro fertilization (IVF) laboratories. However, commercial media are costly and difficult to compare directly because their exact compositions are not clearly indicated. Although commercially available media have commonly been used in most IVF programs worldwide, there are several advantages to the use of in-house synthetic sequential media at IVF laboratories. First, the results of quality control should be reliable due to a stringent protocol setting-up. Second, any direct supplementations or deletions of specific components are feasible to obtain good quality embryos and high pregnancy rates since those components can be defined. Finally, dependence on commercially available media diminishes so that the laboratory can more easily accommodate unexpected situations or problems, such as a sudden increase in IVF patients. Therefore, the present study was conducted to compare the efficacy of in-house MRC media in the human IVF-embryo transfer (ET) program to that of commercially available media.
| Condition | Intervention |
|---|---|
|
Infertility |
Other: MRC media Other: Sydney IVF media |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label |
| Official Title: | Application of Two Different Synthetic Sequential Media for the Human IVF-ET Program |
- Embryo Quality [ Time Frame: 3 Days ] [ Designated as safety issue: Yes ]
- Pregnancy and Implantation rates [ Time Frame: 2 months ] [ Designated as safety issue: Yes ]
| Enrollment: | 360 |
| Study Start Date: | November 2009 |
| Study Completion Date: | October 2010 |
| Primary Completion Date: | September 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: MRC media
Use MRC media in the human IVF-ET program
|
Other: MRC media
Culture media
|
|
Active Comparator: Sydney IVF media
Use Sydney IVF media in the human IVF-ET program
|
Other: Sydney IVF media
Culture media
|
Eligibility| Ages Eligible for Study: | 20 Years to 39 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Patients undergoing IVF treatment in our clinic during study period
Exclusion Criteria:
- Females older than 40 years
- Patients showed fertilization failure
- Patients with less than two 2PN embryos
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Jeong Yoon, Maria Fertility Hospital |
| ClinicalTrials.gov Identifier: | NCT01356238 History of Changes |
| Other Study ID Numbers: | MRC-1 |
| Study First Received: | May 17, 2011 |
| Last Updated: | May 18, 2011 |
| Health Authority: | South Korea: Institutional Review Board |
Additional relevant MeSH terms:
|
Infertility Genital Diseases, Male Genital Diseases, Female |
ClinicalTrials.gov processed this record on May 22, 2013